NCT06107569View on ClinicalTrials.gov

Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

January 1, 2026

Conditions
Clostridium Difficile Infections
Interventions
OTHER

Fecal microbiota transplant (Promicrobioma)

Fecal microbiota transplant with Promicrobioma (freeze-dried isolated microbiota)

DRUG

Antibiotic

Antibiotics for Clostridioides infection (oral vancomycin) or association of intravenous metronidazol for severe cases.

All Listed Sponsors
lead

Hospital Universitario Evangelico de Curitiba

OTHER